{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:22:51Z","timestamp":1779895371355,"version":"3.53.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The conception of collagenase Clostridium histolyticum (CCH) as treatment for Peyronie's disease (PD) was a vital first step in providing a nonsurgical, minimally invasive FDA-approved treatment for men with PD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To review the origins, clinical research history, and ultimately FDA approval of collagenase as PD treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A PubMed search using (Peyronie's or Peyronie) AND collagenase, and limited to clinical research studies, returned nine papers that were examined in the current review.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Collagenase as a PD treatment arose in response to a lack of effective nonsurgical treatments and the incomplete understanding of underlying PD etiology. Awareness of dense collagen in PD scarring and parallel initial exploration of collagenase to treat herniated lumbar discs coincided with and inspired laboratory-based investigation of collagenase effects on excised PD plaque tissue. The foundational conceptual work and the critical development of purified injectable collagenase allowed the pursuit of clinical studies. Progression of clinical studies into large-scale robust trials culminated in two important outcomes: development of the first validated, PD-specific measure of psychosexual function, the Peyronie's Disease Questionnaire, and the first FDA-approved treatment for PD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Collagenase therapy began as an attempt to modify the structure of PD-related tunica albuginea scarring, despite the lack of a fundamental understanding of the scar's origin. If we wish to advance PD treatment beyond this first effective step, the future needs to bring us full circle to the starting point: We need a greater understanding of the control of collagen deposition and wound healing in men with PD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jsm.12904","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T08:35:13Z","timestamp":1430814913000},"page":"1481-1489","source":"Crossref","is-referenced-by-count":22,"title":["Collagenase <i>Clostridium histolyticum<\/i> for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach"],"prefix":"10.1093","volume":"12","author":[{"given":"Martin K.","family":"Gelbard","sequence":"first","affiliation":[{"name":"Urology Associates Medical Group , Burbank, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Chagan","sequence":"additional","affiliation":[{"name":"Auxilium Pharmaceuticals , Chesterbrook, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Tursi","sequence":"additional","affiliation":[{"name":"Auxilium Pharmaceuticals , Chesterbrook, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,6,1]]},"reference":[{"key":"2023012309055013900_bb0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11934-004-0074-y","article-title":"New discoveries in the basic science understanding of Peyronie's disease","volume":"5","author":"Jalkut","year":"2004","journal-title":"Curr Urol Rep"},{"key":"2023012309055013900_bb0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.ijir.3900875","article-title":"Pathophysiology of Peyronie's disease","volume":"14","author":"Moreland","year":"2002","journal-title":"Int J Impot Res"},{"key":"2023012309055013900_bb0020","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ajcp\/45.6.670","article-title":"Peyronie's disease","volume":"45","author":"Smith","year":"1966","journal-title":"Am J Clin Pathol"},{"key":"2023012309055013900_bb0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-5347(01)65367-9","article-title":"Fibrin deposition in Peyronie's disease plaque","volume":"157","author":"Somers","year":"1997","journal-title":"J Urol"},{"issue":"suppl 5","key":"2023012309055013900_bb0030","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1038\/sj.ijir.3901082","article-title":"Expanding the paradigm for plaque development in Peyronie's disease","volume":"15","author":"Mulhall","year":"2003","journal-title":"Int J Impot Res"},{"key":"2023012309055013900_bb0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"2023012309055013900_bb0040","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI102861","article-title":"Isolation and characterization of proteinase and collagenase from Cl. histolyticum","volume":"32","author":"Mandl","year":"1953","journal-title":"J Clin Invest"},{"key":"2023012309055013900_bb0045","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1172\/JCI102860","article-title":"Bacterial digestion of collagen","volume":"32","author":"Maclennan","year":"1953","journal-title":"J Clin Invest"},{"key":"2023012309055013900_bb0050","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/1741191a0","article-title":"Separation of proteolytic enzymes of Clostridium histolyticum","volume":"174","author":"Debellis","year":"1954","journal-title":"Nature"},{"key":"2023012309055013900_bb0055","first-page":"116","article-title":"Clostridium histolyticum collagenases: A new look at some old enzymes","volume":"1","author":"Mookhtiar","year":"1992","journal-title":"Matrix Suppl"},{"key":"2023012309055013900_bb0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/bi00377a004","article-title":"Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: Complementary digestion patterns","volume":"26","author":"French","year":"1987","journal-title":"Biochemistry"},{"key":"2023012309055013900_bb0065","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.transproceed.2011.09.059","article-title":"Characterization and functional assessment of Clostridium histolyticum class I (C1) collagenases and the synergistic degradation of native collagen in enzyme mixtures containing class II (C2) collagenase","volume":"43","author":"Breite","year":"2011","journal-title":"Transplant Proc"},{"key":"2023012309055013900_bb0070","first-page":"1","article-title":"Collangenase comes of age","author":"Mandl","year":"1972","journal-title":"Collangenase"},{"key":"2023012309055013900_bb0075","first-page":"101","article-title":"Experimental intervertebral discolysis with collangenase","author":"Sussman","year":"1972","journal-title":"Collangenase"},{"key":"2023012309055013900_bb0080","first-page":"123","article-title":"Early investigations of the treatment of third degrees burns with collangenase","author":"Howes","year":"1972","journal-title":"Collangenase"},{"key":"2023012309055013900_bb0085","first-page":"131","article-title":"The importance of collangenase for the local treatment of major burns","author":"Zimmerman","year":"1972","journal-title":"Collangenase"},{"key":"2023012309055013900_bb0090","first-page":"177","article-title":"The use of Clostridium histolyticum enzymes in the treatment of experimental third degree burns","volume":"109","author":"Howes","year":"1959","journal-title":"Surg Gynecol Obstet"},{"key":"2023012309055013900_bb0095","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00007632-198407000-00012","article-title":"Double-blind evaluation of collagenase injections for herniated lumbar discs","volume":"9","author":"Bromley","year":"1984","journal-title":"Spine"},{"key":"2023012309055013900_bb0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/jb.79.2.191-197.1960","article-title":"Toxicity of enzymes from Clostridium histolyticum","volume":"79","author":"Howes","year":"1960","journal-title":"J Bacteriol"},{"key":"2023012309055013900_bb0105","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00007632-198507000-00010","article-title":"Effects of collagenase on nerve tissue. An experimental study on acute and long-term effects in rabbits","volume":"10","author":"Rydevik","year":"1985","journal-title":"Spine"},{"key":"2023012309055013900_bb0110","first-page":"17","article-title":"Microvascular response to locally injected collagenase. An experimental investigation in hamsters and rabbits","volume":"23","author":"Rydevik","year":"1989","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"2023012309055013900_bb0115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0363-5023(96)80368-6","article-title":"Collagenase in the treatment of Dupuytren's disease: An in vitro study","volume":"21","author":"Starkweather","year":"1996","journal-title":"J Hand Surg [Am]"},{"key":"2023012309055013900_bb0120","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1517\/14712598.2010.510509","article-title":"Collagenase Clostridium histolyticum for Dupuytren's contracture","volume":"10","author":"Desai","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"2023012309055013900_bb0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-642-22697-7_17","article-title":"A primer of collagen biology: Synthesis, degradation, subtypes, and role in Dupuytren's disease","author":"Hart","year":"2012","journal-title":"Dupuytren's disease and related hyperproliferative disorders: Principles, research, and clinical perspectives"},{"key":"2023012309055013900_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/bip.10201","article-title":"Matrix metalloproteinases and collagen catabolism","volume":"66","author":"Lauer-Fields","year":"2002","journal-title":"Biopolymers"},{"key":"2023012309055013900_bb0135","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc Res"},{"key":"2023012309055013900_bb0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/bj1390359","article-title":"The interaction of \u03b12-macroglobulin with proteinases. Binding and inhibition of mammalian collagenases and other metal proteinases","volume":"139","author":"Werb","year":"1974","journal-title":"Biochem J"},{"key":"2023012309055013900_bb0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpuro0201","article-title":"Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie's disease","volume":"2","author":"Gonzalez-Cadavid","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"2023012309055013900_bb0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrurol.2010.24","article-title":"Treatment of Peyronie's disease with PDE5 inhibitors: An antifibrotic strategy","volume":"7","author":"Gonzalez-Cadavid","year":"2010","journal-title":"Nat Rev Urol"},{"key":"2023012309055013900_bb0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/wound.2012.0393","article-title":"Mechanoregulation of the myofibroblast in wound contraction, scarring, and fibrosis: Opportunities for new therapeutic intervention","volume":"2","author":"Van De Water","year":"2013","journal-title":"Adv Wound Care"},{"key":"2023012309055013900_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2023012309055013900_bb0165","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/j.1743-6109.2008.01011.x","article-title":"Myofibroblasts and mechanotransduction: Do forces in the tunica albuginea contribute to Peyronie's disease?","volume":"5","author":"Gelbard","year":"2008","journal-title":"J Sex Med"},{"key":"2023012309055013900_bb0170","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0090-4295(80)90028-X","article-title":"Clostridial collagenase and Peyronie disease","volume":"15","author":"Gelbard","year":"1980","journal-title":"Urology"},{"key":"2023012309055013900_bb0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00255956","article-title":"Collagenase for Peyronie's disease experimental studies","volume":"10","author":"Gelbard","year":"1982","journal-title":"Urol Res"},{"issue":"suppl 4","key":"2023012309055013900_bb0180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0022-5347(09)60794-1","article-title":"Comparative analysis of collagen degradation in Peyronie's disease plaque and Dupuytren's contracture cord tissues injected with mixed collagenase subtypes","volume":"181","author":"Del Carlo","year":"2009","journal-title":"J Urol"},{"key":"2023012309055013900_bb0185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-5347(17)47123-0","article-title":"The use of collagenase in the treatment of Peyronie's disease","volume":"134","author":"Gelbard","year":"1985","journal-title":"J Urol"},{"key":"2023012309055013900_bb0190","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0022-5347(17)45768-5","article-title":"Humoral immune responses in Peyronie's disease patients receiving clostridial collagenase therapy","volume":"135","author":"Hamilton","year":"1986","journal-title":"J Urol"},{"key":"2023012309055013900_bb0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-5347(17)35998-0","article-title":"Collagenase vs. placebo in the treatment of Peyronie's disease: A double-blind study","volume":"149","author":"Gelbard","year":"1993","journal-title":"J Urol"},{"key":"2023012309055013900_bb0200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1743-6109.2007.00651.x","article-title":"The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: A prospective, single-center, non-placebo-controlled study","volume":"5","author":"Jordan","year":"2008","journal-title":"J Sex Med"},{"key":"2023012309055013900_bb0205","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","article-title":"Phase 2b study of clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie's disease","volume":"187","author":"Gelbard","year":"2012","journal-title":"J Urol"},{"key":"2023012309055013900_bb0210","article-title":"Xiaflex\u00ae (collagenase Clostridium histolyticum) [prescribing information]","year":"2014"},{"key":"2023012309055013900_bb0215","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/j.1743-6109.2008.00883.x","article-title":"Impact of Peyronie's disease on sexual and psychosocial functioning: Qualitative findings in patients and controls","volume":"5","author":"Rosen","year":"2008","journal-title":"J Sex Med"},{"key":"2023012309055013900_bb0220","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","article-title":"Bother and distress associated with Peyronie's disease: Validation of the Peyronie's Disease Questionnaire (PDQ)","volume":"190","author":"Hellstrom","year":"2013","journal-title":"J Urol"},{"key":"2023012309055013900_bb0225","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase Clostridium histolyticum for Dupuytren's contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"2023012309055013900_bb0230","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1743-6109.2008.01081.x","article-title":"Peyronie's disease intervention trials: Methodological challenges and issues","volume":"6","author":"Muller","year":"2009","journal-title":"J Sex Med"},{"key":"2023012309055013900_bb0235","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie's disease: Evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515310419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515310419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/6\/1481\/48586223\/jsm_12_6_1481.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/6\/1481\/48586223\/jsm_12_6_1481.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T14:42:55Z","timestamp":1675953775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/12\/6\/1481\/6980111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,1]]},"published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12904","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,6]]},"published":{"date-parts":[[2015,6,1]]}}}